Sphera Funds Management LTD. — 13F Holdings

2026 Q3  ·  136 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, SPHERA FUNDS MANAGEMENT LTD. maintained a portfolio of 136 distinct positions. The most significant new addition was TEVA PHARMACEUTICAL INDS LTD, now representing 4.60% of the total fund value. They heavily accumulated shares in ALNYLAM PHARMACEUTICALS INC, increasing the position by 1016.7%. Conversely, SPHERA FUNDS MANAGEMENT LTD. completely exited their position in TEVA PHARMACEUTICAL INDS LTD.
Position History hover any row below to update
Loading…
SPHERA FUNDS MANAGEMENT LTD. Tel Aviv Hedge Fund / Asset Manager AUM $660M
PCA Score Concentration Risk
Risk ENB
Total Positions
136
Quarter
2026 Q3
Top Holding
MLYS (4.7%)
Top 10 Concentration
33.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 136

SPHERA FUNDS MANAGEMENT LTD. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
MLYS
MINERALYS THERA...
Healthcare 4.70% 5.17% #1 1
Prev: #2
4.4
—
-148,110 -10.1%
P
S
1,321,861 $33,218,367 2023 Q1 13F Filing 2026-09-30 2026-11-16
TEVJF
TEVA PHARMACEUT...
Healthcare 4.60% — #2
Prev: #—
6.8
—
821,282 —
NEW
821,282 $32,522,767 2026 Q3 13F Filing 2026-09-30 2026-11-16
ALNY
ALNYLAM PHARMAC...
Healthcare 4.21% 0.42% #3 74
Prev: #77
5.7
—
109,802 1016.7%
P
S
120,602 $29,757,337 2015 Q2 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 3.37% 2.44% #4 6
Prev: #10
4.8
—
141,910 64.5%
P
S
361,897 $23,852,631 2013 Q4 13F Filing 2026-09-30 2026-11-16
SOXX
ISHARES TR
ETF 2.97% — #5
Prev: #—
5.2
—
37,000 —
NEW
37,000 $21,039,680 2026 Q3 13F Filing 2026-09-30 2026-11-16
BBIO
BRIDGEBIO PHARM...
Healthcare 2.90% 2.38% #6 5
Prev: #11
3.7
—
66,371 27.1%
P
S
311,717 $20,510,979 2020 Q4 13F Filing 2026-09-30 2026-11-16
TSEM
TOWER SEMICONDU...
Technology 2.72% 3.68% #7 4
Prev: #3
1.1
—
-23,525 -21.7%
P
S
84,740 $19,272,418 2016 Q4 13F Filing 2026-09-30 2026-11-16
SNDX
SYNDAX PHARMACE...
Healthcare 2.68% 2.89% #8 3
Prev: #5
1.6
—
-7,328 -0.7%
P
S
1,007,278 $18,936,826 2016 Q3 13F Filing 2026-09-30 2026-11-16
BMRN
BIOMARIN PHARMA...
Healthcare 2.49% 2.45% #9
Prev: #9
1.5
—
-35,304 -10.7%
P
S
293,246 $17,594,760 2014 Q2 13F Filing 2026-09-30 2026-11-16
BIIB
BIOGEN INC
Healthcare 2.42% 2.72% #10 3
Prev: #7
1.0
—
-20,863 -21.6%
P
S
75,763 $17,113,346 2013 Q4 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 2.27% 2.32% #11 1
Prev: #12
2.9
—
42,200 9.2%
P
S
501,540 $16,059,311 2020 Q4 13F Filing 2026-09-30 2026-11-16
NVMI
NOVA LTD
Technology 2.13% 1.78% #12 1
Prev: #13
3.9
—
13,875 55.1%
P
S
39,044 $15,039,749 2014 Q1 13F Filing 2026-09-30 2026-11-16
MDGL
MADRIGAL PHARMA...
Healthcare 1.84% 1.22% #13 7
Prev: #20
3.2
—
8,376 48.1%
P
S
25,795 $12,999,648 2023 Q1 13F Filing 2026-09-30 2026-11-16
XBI
SPDR SERIES TRU...
PUT
PUT Option 1.67% 3.10% #14 10
Prev: #4
0.7
—
-75,000 -50.0%
P
S
75,000 $11,825,999 2017 Q3 13F Filing 2026-09-30 2026-11-16
META
META PLATFORMS ...
Communication Services 1.66% — #15
Prev: #—
4.2
—
16,200 —
NEW
16,200 $11,747,916 2016 Q4 13F Filing 2026-09-30 2026-11-16
IMTX
IMMATICS N.V
Healthcare 1.62% 0.95% #16 21
Prev: #37
3.6
—
584,675 81.2%
P
S
1,304,732 $11,455,547 2020 Q3 13F Filing 2026-09-30 2026-11-16
SNY
SANOFI SA
Healthcare 1.57% 1.50% #17
Prev: #17
1.6
—
no change no change
P
S
269,515 $11,112,103 2014 Q1 13F Filing 2026-09-30 2026-11-16
AZNCF
ASTRAZENECA PLC
Unknown 1.56% 1.55% #18 2
Prev: #16
2.6
—
6,000 9.6%
P
S
68,530 $11,065,539 2026 Q1 13F Filing 2026-09-30 2026-11-16
ARKG
ARK ETF TR
PUT
PUT Option 1.53% — #19
Prev: #—
4.1
—
200,000 —
NEW
200,000 $10,844,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
MAZE
MAZE THERAPEUTI...
Healthcare 1.41% 1.63% #20 5
Prev: #15
1.1
—
-51,276 -12.3%
P
S
366,288 $9,955,708 2025 Q1 13F Filing 2026-09-30 2026-11-16
LLY
ELI LILLY & CO
Healthcare 1.31% 1.26% #21 2
Prev: #19
1.5
—
no change no change
P
S
8,040 $9,302,923 2014 Q1 13F Filing 2026-09-30 2026-11-16
KLAC
KLA CORP
Technology 1.25% — #22
Prev: #—
4.0
—
45,220 —
NEW
45,220 $8,814,735 2024 Q2 13F Filing 2026-09-30 2026-11-16
LRCX
LAM RESEARCH CO...
Technology 1.20% 1.04% #23 4
Prev: #27
3.0
—
7,430 40.2%
P
S
25,900 $8,508,409 2017 Q2 13F Filing 2026-09-30 2026-11-16
PFE
PFIZER INC
Healthcare 1.15% 0.90% #24 15
Prev: #39
1.5
—
no change no change
P
S
286,000 $8,156,720 2013 Q4 13F Filing 2026-09-30 2026-11-16
IDYA
IDEAYA BIOSCIEN...
Healthcare 1.15% 0.95% #25 11
Prev: #36
2.5
—
15,000 7.6%
P
S
211,408 $8,122,295 2021 Q1 13F Filing 2026-09-30 2026-11-16
RYTM
RHYTHM PHARMACE...
Healthcare 1.08% 1.16% #26 2
Prev: #24
1.4
—
no change no change
P
S
80,400 $7,655,286 2026 Q2 13F Filing 2026-09-30 2026-11-16
JNJ
JOHNSON & JOHNS...
Healthcare 1.08% 0.96% #27 8
Prev: #35
1.4
—
no change no change
P
S
28,831 $7,632,719 2013 Q4 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 1.07% 1.04% #28 1
Prev: #29
2.4
—
50,000 19.7%
P
S
304,250 $7,591,038 2024 Q3 13F Filing 2026-09-30 2026-11-16
IRON
DISC MEDICINE I...
Healthcare 1.06% 0.61% #29 28
Prev: #57
3.4
—
51,200 80.6%
P
S
114,738 $7,510,749 2023 Q1 13F Filing 2026-09-30 2026-11-16
VOR
VOR BIOPHARMA I...
Healthcare 1.03% 1.00% #30 2
Prev: #32
0.9
—
-33,000 -7.9%
P
S
383,417 $7,315,596 2025 Q4 13F Filing 2026-09-30 2026-11-16
AMAT
APPLIED MATLS I...
Technology 1.03% 1.04% #31 3
Prev: #28
2.9
—
3,260 29.5%
P
S
14,300 $7,312,734 2021 Q3 13F Filing 2026-09-30 2026-11-16
ABVX
ABIVAX SA
Healthcare 1.03% — #32
Prev: #—
3.9
—
73,716 —
NEW
73,716 $7,299,358 2026 Q2 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS N V
Healthcare 1.03% — #33
Prev: #—
3.9
—
229,700 —
NEW
229,700 $7,286,084 2023 Q4 13F Filing 2026-09-30 2026-11-16
CAMT
CAMTEK LTD
Technology 1.03% — #34
Prev: #—
3.9
—
46,800 —
NEW
46,800 $7,265,700 2017 Q2 13F Filing 2026-09-30 2026-11-16
MRK
MERCK & CO INC
Healthcare 1.00% 0.98% #35 1
Prev: #34
0.9
—
-10,000 -17.1%
P
S
48,600 $7,062,066 2013 Q4 13F Filing 2026-09-30 2026-11-16
NVCT
NUVECTIS PHARMA...
Healthcare 0.97% 0.92% #36 2
Prev: #38
0.9
—
-59,520 -15.5%
P
S
323,425 $6,830,736 2026 Q2 13F Filing 2026-09-30 2026-11-16
NVS
NOVARTIS AG
Healthcare 0.91% 1.02% #37 7
Prev: #30
0.9
—
-5,000 -10.0%
P
S
45,000 $6,412,843 2013 Q4 13F Filing 2026-09-30 2026-11-16
ABBV
ABBVIE INC
Healthcare 0.82% 0.99% #38 5
Prev: #33
0.3
—
-8,000 -26.4%
P
S
22,256 $5,821,947 2014 Q3 13F Filing 2026-09-30 2026-11-16
TRAX
FIRST TRACKS BI...
Healthcare 0.80% 0.07% #39 61
Prev: #100
3.3
—
132,361 474.8%
P
S
160,237 $5,678,799 2026 Q2 13F Filing 2026-09-30 2026-11-16
TRVI
TREVI THERAPEUT...
Healthcare 0.78% 1.21% #40 19
Prev: #21
0.3
—
-113,700 -22.8%
P
S
385,329 $5,517,911 2025 Q2 13F Filing 2026-09-30 2026-11-16
MSLE
SATELLOS BIOSCI...
Healthcare 0.77% 0.66% #41 10
Prev: #51
0.8
—
-13,900 -2.1%
P
S
638,690 $5,428,865 2026 Q1 13F Filing 2026-09-30 2026-11-16
ANNX
ANNEXON INC
Healthcare 0.73% — #42
Prev: #—
3.8
—
1,222,687 —
NEW
1,222,687 $5,171,966 2021 Q2 13F Filing 2026-09-30 2026-11-16
RARE
ULTRAGENYX PHAR...
Healthcare 0.72% 2.56% #43 35
Prev: #8
0.3
—
-249,851 -42.5%
P
S
338,643 $5,089,804 2015 Q2 13F Filing 2026-09-30 2026-11-16
CLYM
CLIMB BIO INC
Healthcare 0.68% 0.82% #44 2
Prev: #42
0.8
—
-67,000 -13.9%
P
S
416,747 $4,780,088 2024 Q2 13F Filing 2026-09-30 2026-11-16
CYBN
CYBIN INC
Unknown 0.67% 1.40% #45 27
Prev: #18
0.3
—
-1,232,602 -76.1%
P
S
388,151 $4,770,376 2024 Q1 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 0.67% 1.06% #46 20
Prev: #26
0.3
—
-403,600 -53.6%
P
S
349,383 $4,706,189 2020 Q4 13F Filing 2026-09-30 2026-11-16
RVMD
REVOLUTION MEDI...
Healthcare 0.65% 0.55% #47 17
Prev: #64
1.3
—
no change no change
P
S
22,400 $4,597,824 2025 Q3 13F Filing 2026-09-30 2026-11-16
NVO
NOVO-NORDISK A ...
Healthcare 0.65% 0.75% #48 4
Prev: #44
1.3
—
no change no change
P
S
120,677 $4,574,865 2019 Q1 13F Filing 2026-09-30 2026-11-16
ELVN
ENLIVEN THERAPE...
Healthcare 0.65% 0.75% #49 4
Prev: #45
0.8
—
-13,000 -11.5%
P
S
99,765 $4,573,228 2025 Q1 13F Filing 2026-09-30 2026-11-16
TENX
TENAX THERAPEUT...
Healthcare 0.62% 0.23% #50 40
Prev: #90
3.2
—
2,195,496 1826.5%
P
S
2,315,696 $4,376,665 2024 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 136 holdings

Unlock Full SPHERA FUNDS MANAGEMENT LTD. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →